Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/11339
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRao, Y Udaya Bhaskara-
dc.date.accessioned2011-03-22T08:49:03Z-
dc.date.available2011-03-22T08:49:03Z-
dc.date.issued2003-10-
dc.identifier.issn0975-0967 (Online); 0972-5849 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/11339-
dc.description494-498en_US
dc.description.abstractVaccination continues to be the most cost effective, safest and most powerful tool of medicine for preventing sufferings, disability and death from infectious diseases. The traditional vaccines were developed when one knew very little about how the diseases were caused and how the immunity worked. Most of the vaccines were developed by trial and error in animal and human experiments. With the recent advances in molecular biology, immunology and recombinant DNA technology, one can understand how the antigens are processed and presented to the immune system and how that affects immune response. Also the current researches are underway into the mechanism of use of pathogens to infect and cause disease. The developments in vaccinology with DNA vacinnes, transgenic plant vaccines and combination of vaccines promises an exciting area in prevention and control of infectious diseases.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBT Vol.02(4) [October 2003]en_US
dc.subjectVaccinationen_US
dc.subjectDNA vaccinesen_US
dc.subjectImmunizationen_US
dc.subjectImmune responseen_US
dc.subjectCytotoxic T cellsen_US
dc.titleRecent Advances in Vaccinologyen_US
dc.typeArticleen_US
Appears in Collections:IJBT Vol.02(4) [October 2003]

Files in This Item:
File Description SizeFormat 
IJBT 2(4) 494-498.pdf1.12 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.